Follow-up of cognitive impairment and inflammatory profile in individuals with mild COVID-19
Copyright © 2024. Published by Elsevier B.V..
Individuals who experience mild COVID-19 can suffer from long-lasting cognitive symptoms. Notably, 26% of these individuals experience difficulties with visuospatial abilities six months after infection. However, among those who initially exhibited visuoconstructive impairments, 66% showed improvement or complete reversal over time. Additionally, changes in cytokine levels, particularly CCL11, HGF, and CXCL10, were observed. These results suggest a potential link between ongoing cognitive issues and elevated levels of pro-inflammatory cytokines, which merits further investigation.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:389 |
|---|---|
| Enthalten in: |
Journal of neuroimmunology - 389(2024) vom: 15. Apr., Seite 578327 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Souza-Silva, Nathália Gualberto [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cytokines |
|---|
| Anmerkungen: |
Date Completed 08.04.2024 Date Revised 08.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jneuroim.2024.578327 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369796624 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369796624 | ||
| 003 | DE-627 | ||
| 005 | 20240408232715.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240316s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jneuroim.2024.578327 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1369.xml |
| 035 | |a (DE-627)NLM369796624 | ||
| 035 | |a (NLM)38489978 | ||
| 035 | |a (PII)S0165-5728(24)00045-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Souza-Silva, Nathália Gualberto |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Follow-up of cognitive impairment and inflammatory profile in individuals with mild COVID-19 |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.04.2024 | ||
| 500 | |a Date Revised 08.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024. Published by Elsevier B.V. | ||
| 520 | |a Individuals who experience mild COVID-19 can suffer from long-lasting cognitive symptoms. Notably, 26% of these individuals experience difficulties with visuospatial abilities six months after infection. However, among those who initially exhibited visuoconstructive impairments, 66% showed improvement or complete reversal over time. Additionally, changes in cytokine levels, particularly CCL11, HGF, and CXCL10, were observed. These results suggest a potential link between ongoing cognitive issues and elevated levels of pro-inflammatory cytokines, which merits further investigation | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Post-acute COVID-19 syndrome. Neuroinflammation. Cytokine. Cognitive symptoms. Visuospatial processing | |
| 650 | 7 | |a Cytokines |2 NLM | |
| 700 | 1 | |a Rosa, Daniela Valadão |e verfasserin |4 aut | |
| 700 | 1 | |a de Paula, Jonas Jardim |e verfasserin |4 aut | |
| 700 | 1 | |a Coimbra, Roney Santos |e verfasserin |4 aut | |
| 700 | 1 | |a Miranda, Débora Marques |e verfasserin |4 aut | |
| 700 | 1 | |a Romano-Silva, Marco Aurélio |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of neuroimmunology |d 1985 |g 389(2024) vom: 15. Apr., Seite 578327 |w (DE-627)NLM012614181 |x 1872-8421 |7 nnns |
| 773 | 1 | 8 | |g volume:389 |g year:2024 |g day:15 |g month:04 |g pages:578327 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jneuroim.2024.578327 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 389 |j 2024 |b 15 |c 04 |h 578327 | ||